Vladimir Vetoshkin

Head of Research Laboratory at Alliance Digital Fund
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Yekaterinburg, Sverdlovsk, Russia, RU

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Certificate of recognition of foreign higher education and qualifications in the Czech Republic
    Univerzita Karlova
    Sep, 2019
    - Nov, 2024

Experience

    • Czechia
    • Financial Services
    • 1 - 100 Employee
    • Head of Research Laboratory
      • Jan 2019 - Present

      Development of medical and biotechnological directions of a laboratory complex at the base of the Technology Innovation Transfer Chamber Development of medical and biotechnological directions of a laboratory complex at the base of the Technology Innovation Transfer Chamber

    • Head of Research Group
      • May 2015 - Present

      Development of imidazole derivatives as corrosion inhibitors, solvents and inhibitors of Asphaltene-Resin-Paraffin deposits, demulsifiers, clay stabilizers, biocides (e.g. sulfur-reducing bacteria).Development of a full-cycle production of enzyme breakers, superplasticizers for dry mixes. Development of imidazole derivatives as corrosion inhibitors, solvents and inhibitors of Asphaltene-Resin-Paraffin deposits, demulsifiers, clay stabilizers, biocides (e.g. sulfur-reducing bacteria).Development of a full-cycle production of enzyme breakers, superplasticizers for dry mixes.

    • Scientist
      • Jul 2010 - Feb 2018

      Development and study of antiviral triazole-derived nucleotide analogues. Development of production of ready-to-use forms of the antiviral drug "Triazavirin" (aerosol, capsule, injectable and liposomal forms).Support (laboratory and experimental testing; criticism, review) of medical and pharmaceutical projects of Ural Federal University.Study of antimicrobial properties of the antiseptic nanocoating "Dezitol" for the Ural Center of Nanotechnology.Development of a synthetic immunogen for protection against the toxic effects of narcotic and psychoactive substances (RF Patent No. 2526807)

    • Scientist
      • Oct 2003 - Feb 2018

      Development and production of synthetic immunogens and vaccines (anti-opioid immunogen (Patent No. 2236257), immunogen for angiotensins (Patent No. 2259847), immunogen for inactivation of organophosphorus toxins, liposomal form of anti-opioid vaccine, the same vaccine based on dendritic cells, dendritic vaccine for esterified cholesterol, substances and ready-made dosage forms of antitoxic antidotes based on Fab-antibody fragments (IgG).Preparation and purification of preparations based on botulinum toxin.Preparation and purification of lactoferrin-based preparations.Development and production of psychoenergetic agents, analogues of the drugs Acefen, Tonibral.Synthesis of dipeptide analogues of b-alanylhistidine for the production of drugs similar to Carnosine.Synthesis of analogues of endogenous CB1-receptor ligands for the purpose of studying pharmacological properties.

    • Pharmacologist
      • Jul 2010 - Apr 2015

      Quality control of pharmaceutical products, production validation. An industrial method for producing an analog of gamma-interferon has been patented.Patent No. 2454221 " Method for obtaining a lyophilized antiviral agent" Quality control of pharmaceutical products, production validation. An industrial method for producing an analog of gamma-interferon has been patented.Patent No. 2454221 " Method for obtaining a lyophilized antiviral agent"

    • Biologist
      • Sep 2011 - Sep 2014

      Quality control of biological activity of "Rosinsuline" Quality control of biological activity of "Rosinsuline"

    • Russian Federation
    • Medical Practices
    • 1 - 100 Employee
    • Chief lecturer
      • Sep 1997 - Apr 2012

      Educational and methodological work, the formation of professional competencies for the students of the medical faculties.The study of delta-sleep-inducing peptide (DSIP), further "Deltaran" in therapeutic practice. The influence of DSIP on compulsive-obsessive attraction to narcotic substances in the drug addiction model (for example, under immobilization stress and under conditions of free choice). Preparation of synthetic xenobiotic immunogens (in this case, xenobiotics-neurotoxins, psychotropic drugs), their psycho-neuro-immunological study.

Education

  • Ural State Medical University
    pediatrician, clinical pharmacologist
    1990 - 1996

Community

You need to have a working account to view this content. Click here to join now